CN107523552A - 分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 - Google Patents
分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 Download PDFInfo
- Publication number
- CN107523552A CN107523552A CN201710585822.4A CN201710585822A CN107523552A CN 107523552 A CN107523552 A CN 107523552A CN 201710585822 A CN201710585822 A CN 201710585822A CN 107523552 A CN107523552 A CN 107523552A
- Authority
- CN
- China
- Prior art keywords
- amh
- monoclonal antibodies
- antibody
- hybridoma cell
- cell strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004408 hybridoma Anatomy 0.000 title claims abstract description 20
- 210000004027 cell Anatomy 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 16
- 238000002965 ELISA Methods 0.000 claims abstract description 10
- 230000028327 secretion Effects 0.000 claims abstract description 10
- 210000002966 serum Anatomy 0.000 claims abstract description 9
- 230000003248 secreting effect Effects 0.000 claims abstract description 6
- 238000000338 in vitro Methods 0.000 claims abstract description 5
- 244000005700 microbiome Species 0.000 claims abstract description 4
- 238000001514 detection method Methods 0.000 claims description 12
- 238000004321 preservation Methods 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 238000003018 immunoassay Methods 0.000 claims description 4
- 238000009007 Diagnostic Kit Methods 0.000 claims description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 3
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 3
- 210000003024 peritoneal macrophage Anatomy 0.000 claims description 3
- 241001529936 Murinae Species 0.000 claims description 2
- 239000000084 colloidal system Substances 0.000 claims description 2
- 230000004927 fusion Effects 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 210000004988 splenocyte Anatomy 0.000 claims description 2
- 230000007306 turnover Effects 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 239000002356 single layer Substances 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 206010003445 Ascites Diseases 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000007910 cell fusion Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 210000000318 mullerian duct Anatomy 0.000 description 3
- 210000004681 ovum Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000011725 BALB/c mouse Methods 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 210000002149 gonad Anatomy 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- -1 nitrite ions Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 108010005853 Anti-Mullerian Hormone Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102100030173 Muellerian-inhibiting factor Human genes 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 239000000868 anti-mullerian hormone Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
浓度(ng/ml) | 复孔1 | 复孔1 | 均值 |
27.00 | 3.173 | 3.146 | 3.1595 |
9.00 | 2.457 | 2.316 | 2.3865 |
3.00 | 1.202 | 1.107 | 1.1545 |
1.00 | 0.463 | 0.444 | 0.4535 |
0.33 | 0.208 | 0.209 | 0.2085 |
0.11 | 0.143 | 0.151 | 0.147 |
0.04 | 0.087 | 0.086 | 0.0865 |
胎牛血清 | 0.067 | 0.062 | 0.0645 |
AMH-1 | AMH-2 | |
IgA | 0.116 | 0.167 |
IgM | 0.101 | 0.18 |
IgG1 | 0.146 | 0.199 |
IgG2a | 1.14 | 0.101 |
IgG2b | 0.185 | 2.696 |
IgG3 | 0.118 | 0.184 |
Ig-λ | 0.15 | 0.185 |
Ig-κ | 0.964 | 1.679 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710585822.4A CN107523552B (zh) | 2017-07-18 | 2017-07-18 | 分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710585822.4A CN107523552B (zh) | 2017-07-18 | 2017-07-18 | 分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107523552A true CN107523552A (zh) | 2017-12-29 |
CN107523552B CN107523552B (zh) | 2020-11-10 |
Family
ID=60749052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710585822.4A Active CN107523552B (zh) | 2017-07-18 | 2017-07-18 | 分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107523552B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109180814A (zh) * | 2018-09-10 | 2019-01-11 | 宁波奥丞生物科技有限公司 | 一种抗缪勒氏管激素的抗体制备方法 |
CN110128535A (zh) * | 2019-03-27 | 2019-08-16 | 浙江工业大学 | 一种amh单克隆抗体及其制备与应用 |
CN111004326A (zh) * | 2019-12-27 | 2020-04-14 | 苏州博方生物技术有限公司 | 一种抗amh单克隆抗体及其制备方法和应用 |
CN111196851A (zh) * | 2018-11-20 | 2020-05-26 | 厦门万泰凯瑞生物技术有限公司 | 针对人抗缪勒管激素的特异性抗体及其应用 |
WO2022100263A1 (zh) * | 2020-11-12 | 2022-05-19 | 东莞市朋志生物科技有限公司 | 抗amh的抗体、检测amh的试剂和试剂盒 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106674348A (zh) * | 2017-01-06 | 2017-05-17 | 刘玲 | 抗苗勒管激素抗体及其制备方法 |
-
2017
- 2017-07-18 CN CN201710585822.4A patent/CN107523552B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106674348A (zh) * | 2017-01-06 | 2017-05-17 | 刘玲 | 抗苗勒管激素抗体及其制备方法 |
Non-Patent Citations (2)
Title |
---|
MUMFORD SL等: "Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome", 《J.CLIN ENDOCRINOL METAB》 * |
PEARSON K等: "Assessment of the Access AMH assay as an automated,high-performance replacement for the AMH Generation II manual ELISA", 《REPRODUCTIVE BIOLOGY & ENDOCRINOLOGY》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109180814A (zh) * | 2018-09-10 | 2019-01-11 | 宁波奥丞生物科技有限公司 | 一种抗缪勒氏管激素的抗体制备方法 |
CN111196851A (zh) * | 2018-11-20 | 2020-05-26 | 厦门万泰凯瑞生物技术有限公司 | 针对人抗缪勒管激素的特异性抗体及其应用 |
WO2020103691A1 (zh) * | 2018-11-20 | 2020-05-28 | 厦门万泰凯瑞生物技术有限公司 | 针对人抗缪勒管激素的特异性抗体及其应用 |
CN111196851B (zh) * | 2018-11-20 | 2021-11-16 | 厦门万泰凯瑞生物技术有限公司 | 针对人抗缪勒管激素的特异性抗体及其应用 |
CN110128535A (zh) * | 2019-03-27 | 2019-08-16 | 浙江工业大学 | 一种amh单克隆抗体及其制备与应用 |
CN111004326A (zh) * | 2019-12-27 | 2020-04-14 | 苏州博方生物技术有限公司 | 一种抗amh单克隆抗体及其制备方法和应用 |
WO2022100263A1 (zh) * | 2020-11-12 | 2022-05-19 | 东莞市朋志生物科技有限公司 | 抗amh的抗体、检测amh的试剂和试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN107523552B (zh) | 2020-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107523552A (zh) | 分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 | |
Brodeur et al. | Parameters affecting ascites tumour formation in mice and monoclonal antibody production | |
CN102675463B (zh) | 一种多菌灵单克隆抗体及其制备方法与应用 | |
CN105112398A (zh) | 一种杂交瘤细胞的制备及其分泌的单抗与应用 | |
CN105695419A (zh) | 杂交瘤细胞株4C9及其产生的抗His标签蛋白单克隆抗体 | |
CN106916225A (zh) | 一种检测n端脑钠肽前体的单克隆抗体及其杂交瘤细胞株和应用 | |
CN107271685A (zh) | 一种检测禽白细胞介素2含量的方法及其专用试剂盒 | |
CN110407937A (zh) | 一种抗amh单克隆抗体的制备及其应用 | |
CN103695376A (zh) | 分泌猪圆环病毒2型Cap蛋白单克隆抗体的杂交瘤细胞株 | |
CN104312978B (zh) | 一种妥布霉素单克隆抗体及其制备方法与应用 | |
CN101620230A (zh) | 一种乳制品中β-内酰胺酶的金标试剂盒及制备方法 | |
Matre et al. | A monoclonal antibody inhibiting human placental Fcγ-receptor activity | |
CN107389920A (zh) | 一种检测禽白细胞介素17a含量的方法及其专用试剂盒 | |
CN110940810A (zh) | 一种检测沙门氏菌毒素的塑封胶体金检测卡 | |
CN102391993B (zh) | 布鲁氏菌检测用杂交瘤细胞株17c8及其产生的单克隆抗体 | |
CN114276456B (zh) | 分泌鼠抗人IgG单克隆抗体的杂交瘤细胞株及其分泌的单克隆抗体和应用 | |
CN106244562B (zh) | 杂交瘤细胞株及其分泌的抗25羟基维生素d3单克隆抗体和应用 | |
CN102676459A (zh) | 一种抗副溶血弧菌耐热溶血毒素单克隆抗体及其制备方法 | |
CN104789535B (zh) | 抗美沙酮代谢物eddp杂交瘤细胞株及其制备方法和应用 | |
CN115651915A (zh) | 分泌抗猫b型血型特异性单克隆抗体的杂交瘤细胞株、单克隆抗体及其应用 | |
CN102181402B (zh) | 高致病性猪繁殖与呼吸综合征病毒单克隆抗体及其制备 | |
CN104004718A (zh) | 一株抗吡利霉素通用单克隆抗体杂交瘤细胞株及其应用 | |
CN107058240A (zh) | 一株杂交瘤细胞株ab1及其产生的2,4,5‑三氯苯氧乙酸单克隆抗体 | |
CN100462432C (zh) | 杂交瘤细胞株及其产生的抗人肝素酶单克隆抗体 | |
Damjanov et al. | Origin of laminin in the extracellular matrix of human tumor xenografts in nude mice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240604 Address after: Room 201, Building 5, No. 519 Xingguo Road, Qianjiang Economic Development Zone, Hangzhou City, Zhejiang Province, 310000 Patentee after: HANGZHOU BIOGENOME BIOTECHNOLOGY CO.,LTD. Country or region after: China Patentee after: Chongqing Boshengte Biotechnology Co.,Ltd. Address before: Room 201, Building 5, No. 519 Xingguo Road, Qianjiang Economic Development Zone, Hangzhou City, Zhejiang Province, 310000 Patentee before: HANGZHOU BIOGENOME BIOTECHNOLOGY CO.,LTD. Country or region before: China |